
News & Trends - MedTech & Diagnostics

Medibank launches pharmacogenetic testing while government stalls on insurance discrimination ban
Medibank has become the first Australian health insurer to pay towards pharmacogenetic testing (PGx) for eligible customers on Extras cover. […]
MoreNews & Trends - MedTech & Diagnostics

Long game in cancer control pays off while the clock ticks on future risk
More than 230,000 lives have been saved in Australia thanks to investment in cancer prevention, screening, and treatment. The study […]
MoreNews & Trends - MedTech & Diagnostics

National push to fix the nation’s fragmented medical imaging system
The Royal Australian and New Zealand College of Radiologists (RANZCR) and the Australian Diagnostic Imaging Association (ADIA) have commenced a […]
MoreNews & Trends - MedTech & Diagnostics

Landmark study exposes stark differences in ICD battery life and patient risk
A new independent study examining over 35,000 implantable cardioverter-defibrillators (ICDs) has uncovered significant differences in battery longevity across several medtech […]
MoreNews & Trends - MedTech & Diagnostics

Pathology indexation reboot leaves essential services behind
After nearly three decades of stagnation, the federal government has reinstated annual indexation for selected Medicare Benefits Schedule (MBS) pathology […]
MoreNews & Trends - MedTech & Diagnostics

Abbott’s leadless pacemaker now on Prescribed List
Abbott’s single chamber transcatheter leadless pacemaker is now listed on the Prescribed List (PL), broadening its access to privately insured […]
MoreNews & Trends - MedTech & Diagnostics

The kidney cut-off: Why First Nations patients aren’t making the transplant list
Access to kidney transplantation continues to highlight significant disparities, particularly affecting Aboriginal and Torres Strait Islander populations who face a […]
MoreNews & Trends - MedTech & Diagnostics

When patient safety meets the clock: Hospitals caught in the crossfire of targets and turmoil
Public hospitals find themselves in the throes of a dual crisis: declining productivity amid surging demand, pushing total system costs […]
MoreNews & Trends - MedTech & Diagnostics

Australia charts a new path for precision medicine
Stakeholders have welcomed the formal establishment of Genomics Australia as a national body under the Department of Health and Aged […]
MoreNews & Trends - MedTech & Diagnostics

Public fury erupts amid Bupa scandal
The ACCC legal action against Bupa has triggered a wave of public reaction where consumers expressed intense emotions ranging from […]
MoreRecent Posts in Pharma, MedTech & Biotech
Australia joins Medtronic trial in fight against resistant hypertension
July 11, 2025
in News & Trends - MedTech & Diagnostics
Medibank launches pharmacogenetic testing while government stalls on insurance discrimination ban
July 11, 2025
in News & Trends - MedTech & Diagnostics
Global pledge shifts visibility and action for patients with advanced breast cancer
July 11, 2025
in News & Trends - Pharmaceuticals
Long game in cancer control pays off while the clock ticks on future risk
July 10, 2025
in News & Trends - MedTech & Diagnostics
National push to fix the nation’s fragmented medical imaging system
July 10, 2025
in News & Trends - MedTech & Diagnostics
Pharma tariffs: Australia sidelined as Trump cuts deals elsewhere
July 10, 2025
in News & Trends - Pharmaceuticals
Landmark study exposes stark differences in ICD battery life and patient risk
July 9, 2025
in News & Trends - MedTech & Diagnostics
Industry roundtable to shape Australia’s genomics policy
July 9, 2025
in News & Trends - Pharmaceuticals
Follow Us
Partner with us
News & Trends - MedTech & Diagnostics

Australia joins Medtronic trial in fight against resistant hypertension
Medtronic has launched an international clinical trial across Australia, the United States, and Europe to evaluate the feasibility of multi-organ […]
MoreNews & Trends - MedTech & Diagnostics

Medibank launches pharmacogenetic testing while government stalls on insurance discrimination ban
Medibank has become the first Australian health insurer to pay towards pharmacogenetic testing (PGx) for eligible customers on Extras cover. […]
MoreNews & Trends - Pharmaceuticals

Global pledge shifts visibility and action for patients with advanced breast cancer
Three breast cancer organisations have united internationally to demand that people living with metastatic breast cancer (MBC) are no longer […]
MoreNews & Trends - MedTech & Diagnostics

Long game in cancer control pays off while the clock ticks on future risk
More than 230,000 lives have been saved in Australia thanks to investment in cancer prevention, screening, and treatment. The study […]
More